Streetbeat News

SGTX

Sigilon Therapeutics Inc

Employees

Industry

Pharmaceutical Preparation Manufacturing

harnessing the full power of cell therapeutics. cambridge, ma

Open

22.90

Mkt cap

56M

Volume

82K

High

23.08

P/E Ratio

-1.52

52-wk high

28.00

Low

22.09

Div yield

N/A

52-wk low

3.77

Insider trades were noted in three healthcare stocks: Royal Caribbean Cruises Ltd. (RCL), Sarepta Therapeutics, Inc. (SRPT), and Sigilon Therapeutics, Inc. (SGTX). RCL's director acquired 1,000 shares, indicating confidence in the company's prospects after reporting Q2 sales growth. SRPT's director acquired 23,686 shares following a narrower-than-expected Q2 loss. Shenandoah Acquisition Corp, a 10% owner of SGTX, bought 1,718,493 shares after Eli Lilly agreed to acquire the company.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 11:44 am

Canaccord Genuity analyst Whitney Ijem maintains a Buy rating on Sigilon Therapeutics (NASDAQ:SGTX) and raises the price target from $6 to $30.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 11:48 am

Morgan Stanley analyst Matthew Harrison maintains an Equal-Weight rating on Sigilon Therapeutics (NASDAQ:SGTX) and raises the price target from $7 to $21.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2023 | 12:33 pm

Morgan Stanley analyst Matthew Harrison maintains an Equal-Weight rating on Sigilon Therapeutics (NASDAQ:SGTX) and raises the price target from $7 to $21.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 1:08 pm

BTIG analyst Thomas Shrader has downgraded Sigilon Therapeutics (NASDAQ:SGTX) from Buy to Neutral.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 8:50 am

US stocks traded mixed with Dow Jones gaining and NASDAQ remaining unchanged. Top trending stocks included Aurinia Pharmaceuticals, Nike, Tesla, Goldman Sachs Group, and Sigilon Therapeutics. Aurinia is exploring strategic alternatives including a potential sale or merger. Nike reported a 10% YoY increase in Q4 revenue. Tesla may have had a strong Q2 in Australia. Goldman Sachs rose after clearing Federal Reserve's stress tests. Sigilon's shares skyrocketed after Eli Lilly agreed to acquire the company.

Portfolio Pulse from Benzinga Newsbot

June 30, 2023 | 1:01 am

US stocks traded higher with the Dow Jones gaining more than 200 points. Acuity Brands reported better-than-expected earnings for its third quarter but missed the consensus on net sales. Sigilon Therapeutics shares shot up 505% after Eli Lilly agreed to acquire the company. Shares of Eco Wave Power Global and Immunome also rose after announcing a share repurchase program and a definitive merger agreement respectively. BioXcel Therapeutics, Greenlane Holdings, and Mobiquity Technologies shares dropped after releasing topline results from a Phase 3 trial, announcing a public offering, and reporting pricing of a public offering respectively.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 6:32 pm

Several stocks experienced significant movement in Thursday's mid-day session. Sigilon Therapeutics (SGTX) shares climbed 523.8% after Eli Lilly agreed to acquire the company. Eco Wave Power Global (WAVE) gained 47.4% after announcing plans for a share repurchase program. Franklin Covey Co. (FC) gained 25.2% following upbeat Q3 results. Carriage Services (CSV) surged 24.4% after its Board initiated a process to explore potential strategic alternatives. The Greenbrier Companies (GBX) gained 23.2% after reporting better-than-expected Q3 results and raising FY23 revenue guidance. On the downside, BioXcel Therapeutics (BTAI) shares dipped 62.2% after releasing topline results from a Phase 3 trial.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 5:52 pm

During Thursday's intraday session, several healthcare stocks experienced significant movements. Sigilon Therapeutics (SGTX), Immunome (IMNM), Kintara Therapeutics (KTRA), Trxade Health (MEDS), Adamis Pharmaceuticals (ADMP), and Inovio Pharmaceuticals (INO) saw their shares rise, with Sigilon Therapeutics leading the gainers with a 506.6% increase. On the other hand, BioXcel Therapeutics (BTAI), Cormedix (CRMD), Liquidia (LQDA), ATI Physical Therapy (ATIP), Lumos Pharma (LUMO), and Sientra (SIEN) saw their shares decline, with BioXcel Therapeutics leading the losers with a 65.8% decrease.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 5:37 pm

U.S. stocks traded higher with the Dow Jones gaining more than 200 points. McCormick & Co Inc reported better-than-expected earnings for its second quarter. Sigilon Therapeutics shares shot up 516% after Eli Lilly agreed to acquire the company. Shares of Eco Wave Power Global and Franklin Covey Co. also rose significantly. However, shares of BioXcel Therapeutics, Greenlane Holdings, and Mobiquity Technologies fell.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 4:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.